References
- Zavorotinskaya T, Tomkinson A, Murphy J E. Treatment of experimental asthma by long-term gene therapy directed against IL-4 and IL-13. Mol Ther 2003; 7: 155–162
- Steinke J W, Borish L. Th2 cytokines and asthma. Interleukin-4: its role in the pathogenesis of asthma, and targeting it for asthma treatment with interleukin-4 receptor antagonists. Respir Res 2001; 2: 66–70
- Wynn T A. IL-13 effector functions. Annu Rev Immunol. 2003; 21: 425–456
- Perkins C, Wills-Karp M, Finkelman F D. IL-4 induces IL-13-independent allergic airway inflammation. J Allergy Clin Immunol 2006; 118: 410–409
- Fulkerson P C, Fischetti C A, Hassman L M, Nikolaidis N M, Rothenberg M E. Persistent effects induced by IL-13 in the lung. Am J Respir Cell Mol Biol 2006; 35: 337–346
- Nelms K, Keegan A D, Zamorano J, Ryan J J, Paul W E. The IL-4 receptor: signaling mechanisms and biologic functions. Annu Rev Immunol 1999; 17: 701
- de Vries J E. The role of IL-13 and its receptor in allergy and inflammatory responses. J. Allergy Clin Immunol 1998; 102: 165
- Andrews A L, Holloway J W, Holgate S T, Davies D E. IL-4 receptor alpha is an important modulator of IL-4 and IL-13 receptor binding: implications for the development of therapeutic targets. J Immunol 2006; 176: 7456–7461
- Grunewald S M, Werthmann A, Schnarr B, Klein C E, Brocker E B, Mohrs M, Brombacher F, Sebald W, Duschl A. An antagonistic IL-4 mutant prevents type I allergy in the mouse: inhibition of the IL-4/IL-13 receptor system completely abrogates humoral immune response to allergen and development of allergic symptoms in vivo. J Immunol 1998; 160: 4004
- Tomkinson A, Duez C, Cieslewicz G, Pratt J C, Joetham A, Shanafelt M C, Gundel R, Gelfand E W. A murine IL-4 receptor antagonist that inhibits IL-4- and IL-13-induced responses prevents antigen-induced airway eosinophilia and airway hyperresponsiveness. J Immunol 2001; 166: 5792–5800
- Nishikubo K, Murata Y, Tamaki S, Sugama K, Imanaka-Yoshida K, Yuda N, Kai M, Takamura S, Sebald W, Adachi Y, Yasutomi Y. A single administration of interleukin-4 antagonistic mutant DNA inhibits allergic airway inflammation in a mouse model of asthma. Gene Ther 2003; 10: 2119–2125
- Oh S W, Pae C I, Lee D K, Jones F, Chiang G K, Kim H O, Moon S H, Cao B, Ogbu C, Jeong K W, Kozu G, Nakanishi H, Kahn M, Chi E Y, Henderson W R, Jr. Tryptase inhibition blocks airway inflammation in a mouse asthma model. J Immunol 2002; 168: 1992–2000
- Champion H C, Bivalacqua T J, Greenberg S S, Giles T D, Hyman A L, Kadowitz P J. Adenoviral gene transfer of endothelial nitric-oxide synthase (eNOS) partially restores normal pulmonary arterial pressure in eNOS-deficient mice. Proc Natl Acad Sci U S A 2002; 99: 13248–13253
- Hsieh C S, Macatonia S E, Tripp C S, Wolf S F, O'Garra A, Murphy K M. Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 1993; 260: 496–497
- Ohmori Y, Hamilton T A. STAT6 is required for the anti-inflammatory activity of interleukin-4 in mouse peritoneal macrophages. J Biol Chem 1998; 273: 29202–292029
- Lee S Y, Kim S J, Kwon S S, Kim Y K, Kim K H, Moon H S, Song J S, Park S H. Distribution and cytokine production of CD4 and CD8 T-lymphocyte subsets in patients with acute asthma attacks. Ann Allergy Asthma Immunol 2001; 86: 659–664
- Laprise C, Laviolette M, Boutet M, Boulet L P. Asymptomatic airway hyperresponsiveness: relationships with airway inflammation and remodelling. Eur Respir J 1999; 14: 63–73
- Harmanci E, Gulbas Z, Ozdemir N, Elbek O, Isik R. Lymphocyte subtypes in asthma: relationship with the clinical status and bronchial hyperreactivity. Allerg Immunol (Paris) 1998; 30: 245–248
- Kanazawa H, Yoshikawa J. Alterations in T-lymphocyte subsets in the airways of asthmatic patients with active hepatitis C virus infection. Respiration. 2006; 73: 318–323